NC Medical Research Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Out of Business

NC Medical Research General Information

Description

Developer of a regenerative drug designed to treat cerebral infarctions. The company's product utilizes human bone marrow-derived mesenchymal stem cells as raw material, using a unique manufacturing process, to reduce cerebral infarction size and improve neural function, enabling healthcare providers to have a more effective method over currently followed thrombolytic therapy to treat cerebral infarctions in patients.

Contact Information

Website
www.ncmr.co.jp
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Shiroyama Trust Tower 17th Floor
  • 4-3-1, Toranomon, Minato-ku
  • Tokyo, 105-6017
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Shiroyama Trust Tower 17th Floor
  • 4-3-1, Toranomon, Minato-ku
  • Tokyo, 105-6017
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NC Medical Research Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Out of Business 01-Nov-2026 Completed Out of Business
11. Later Stage VC 05-Aug-2021 Completed Clinical Trials - Phase 2
10. Later Stage VC 01-Apr-2020 Completed Clinical Trials - Phase 2
9. Later Stage VC 01-Apr-2019 Completed Pre-Clinical Trials
8. Later Stage VC 19-Jul-2018 Completed Pre-Clinical Trials
7. Later Stage VC 01-Dec-2017 Completed Pre-Clinical Trials
6. Later Stage VC 01-Feb-2012 Completed Startup
5. Later Stage VC 01-Apr-2011 Completed Startup
4. Later Stage VC 01-May-2009 Completed Startup
3. Early Stage VC 01-Sep-2008 Completed Startup
To view NC Medical Research’s complete valuation and funding history, request access »

NC Medical Research Patents

NC Medical Research Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2017145259-A Cell therapy for treatment of neurodegeneration Active 01-Jun-2017
EP-2953473-A1 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013
EP-2953473-A4 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013
EP-3456817-A1 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013
US-10071144-B2 Cell therapy for the treatment of neurodegeneration Active 06-Feb-2013 A61K38/49
To view NC Medical Research’s complete patent history, request access »

NC Medical Research Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NC Medical Research FAQs

  • When was NC Medical Research founded?

    NC Medical Research was founded in 2004.

  • Where is NC Medical Research headquartered?

    NC Medical Research is headquartered in Tokyo, Japan.

  • What is the size of NC Medical Research?

    NC Medical Research has 1 total employees.

  • What industry is NC Medical Research in?

    NC Medical Research’s primary industry is Drug Discovery.

  • Is NC Medical Research a private or public company?

    NC Medical Research is a Private company.

  • What is NC Medical Research’s current revenue?

    The current revenue for NC Medical Research is .

  • How much funding has NC Medical Research raised over time?

    NC Medical Research has raised $4.54M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process